Fineline Cube

Follow:
14455 Articles
CompanyDeals

Shanghai Kehua Bioengineering’s Subsidiary to Acquire Remaining Stake in Technogenetics S.P.A.

CompanyDrug

Dizal Pharmaceutical’s Golidocitinib Breaks Record with Rapid Market Launch in China

CompanyDeals

GenScript Biotech Receives Over USD 410 Million in Milestone Payments for CAR-T Therapy from Janssen Biotech

CompanyDeals

Jianke.com, China’s Leading Chronic Disease Management Platform, Files for Hong Kong IPO

CompanyDeals

TowardPi Medical Secures RMB 200 Million in Series D Financing Led by Matrix Partners

CompanyDeals

Amoy Diagnostics Partners with Servier to Develop Companion Diagnostic Reagent for IDH Mutations in China

Policy / Regulatory

CDE Seeks Public Input on Latest Batch of Generic Chemical Reference Preparations

CompanyDrug

HighTide Therapeutics Completes Enrollment for Two Phase III Trials of T2DM Drug Candidate HTD1801

CompanyDrug

Shanghai Junshi Biosciences’ Toripalimab Gains NMPA Nod for First-Line TNBC Treatment

CompanyDrug

Harbour BioMed Resubmits Biological License Application for Batoclimab in China

CompanyDeals

Shanghai’s Phrontline Biopharma Secures Over RMB 100 Million in Pre-Series A Funding for ADC Development

CompanyDrug

Antengene’s Xpovio Included in South Korea’s NHIS Reimbursement Drug List